Picture of Collegium Pharmaceutical logo

COLL — Collegium Pharmaceutical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Collegium Pharmaceutical Inc reports results for the quarter ended in September 30 - Earnings Summary

* Collegium Pharmaceutical Inc  COLL.OQ  reported quarterly
adjusted earnings of $1.61​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of 53 cents.  The mean expectation of
five analysts for the quarter was for earnings of $1.59 per
share. Wall Street expected results to range from $1.45 
to $1.84 per share.
    * Revenue rose 16.5% to $159.30 million from a year ago;
analysts
expected $155.57 million. 
    * Collegium Pharmaceutical Inc's reported EPS for the
quarter was
27 cents​.
    * The company reported quarterly net income of $9.34
million.
    * Collegium Pharmaceutical Inc shares had fallen by 10.2%
this
quarter and gained 12.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is 43.00 
This summary was machine generated from LSEG data November 8 at
05:16 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      1.59           1.61           Beat
 Jun. 30 2024      1.49           1.62           Beat
 Mar. 31 2024      0.94           1.45           Beat
 Dec. 31 2023      0.66           0.82           Beat

Recent news on Collegium Pharmaceutical

See all news